GlassScriptPhysician profile
Christopher Wayne Heuer
NPI 1982134367
$3,730.59
in general payments reported to CMS, 2019-2025
7 companies · $15.65 in 2025
The $15.65 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.01 · 2023: $1,033 · 2024: $2,603 · 2025: $15.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023 · Travel and Lodging: $1,446 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.24 |
| Travel and Lodging | $1,445.72 |
| Education | $182.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,372.39 | 2023-2024 | Axonics, Bulkamid |
| Coloplast Corp | $599.12 | 2023-2024 | Altis |
| Boston Scientific Corporation | $597.87 | 2022-2024 | Upsylon, Advantage System, Solyx Sis System |
| Abbvie INC. | $108.34 | 2023 | |
| Valencia Technologies Corporation | $20.93 | 2023 | Ecoin Device Kit |
| Janssen Pharmaceuticals, INC | $16.29 | 2024 | Xarelto |
| Cardiva Medical, INC. | $15.65 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Heuer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.